Global Citalopram Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Citalopram is a selective serotonin reuptake inhibitor (SSRI), a racemate.It can selectively inhibit the 5-ht transporter, block the reuptake of 5-ht by the presynaptic membrane, prolong and increase the effect of 5-ht, and thus produce antidepressant effect.
LPI (LP Information)' newest research report, the “Citalopram Industry Forecast” looks at past sales and reviews total world Citalopram sales in 2022, providing a comprehensive analysis by region and market sector of projected Citalopram sales for 2023 through 2029. With Citalopram sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Citalopram industry.
This Insight Report provides a comprehensive analysis of the global Citalopram landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Citalopram portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Citalopram market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Citalopram and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Citalopram.
The global Citalopram market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Citalopram is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Citalopram is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Citalopram is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Citalopram players cover H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, Silarx Pharmacueticals, Apotex, Hikma Pharmaceuticals and Jubilant Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Citalopram market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Citalopram is a selective serotonin reuptake inhibitor (SSRI), a racemate.It can selectively inhibit the 5-ht transporter, block the reuptake of 5-ht by the presynaptic membrane, prolong and increase the effect of 5-ht, and thus produce antidepressant effect.
LPI (LP Information)' newest research report, the “Citalopram Industry Forecast” looks at past sales and reviews total world Citalopram sales in 2022, providing a comprehensive analysis by region and market sector of projected Citalopram sales for 2023 through 2029. With Citalopram sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Citalopram industry.
This Insight Report provides a comprehensive analysis of the global Citalopram landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Citalopram portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Citalopram market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Citalopram and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Citalopram.
The global Citalopram market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Citalopram is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Citalopram is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Citalopram is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Citalopram players cover H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, Silarx Pharmacueticals, Apotex, Hikma Pharmaceuticals and Jubilant Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Citalopram market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Solution
- Tablets
- Other
- Depression
- Generalized Anxiety
- Obsessive Compulsive Disorder
- Somatoform Disorder
- Schizophrenia
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- H.Lundbeck A/S
- Amneal Pharmaceuticals
- Aurobindo Pharma
- Hetero Drugs
- Macleods Pharmaceuticals
- Silarx Pharmacueticals
- Apotex
- Hikma Pharmaceuticals
- Jubilant Pharma
- Lupin Limited
- Prinston Pharmaceutical
- STI Pharma
- TEVA Pharmaceutical
- Hexal
- Shanghai Great Wall Pharmaceutical
- Wanquan Wante Pharmaceutical
- Northeast Pharmaceutical Group
- Sichuan Kelun Pharmaceutical
- Kunming Jida Pharmaceutical
- Jiangsu Enhua Pharmaceutical
- Southwest Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Citalopram Market Size 2018-2029
2.1.2 Citalopram Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Citalopram Segment by Type
2.2.1 Solution
2.2.2 Tablets
2.2.3 Other
2.3 Citalopram Market Size by Type
2.3.1 Citalopram Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Citalopram Market Size Market Share by Type (2018-2023)
2.4 Citalopram Segment by Application
2.4.1 Depression
2.4.2 Generalized Anxiety
2.4.3 Obsessive Compulsive Disorder
2.4.4 Somatoform Disorder
2.4.5 Schizophrenia
2.4.6 Other
2.5 Citalopram Market Size by Application
2.5.1 Citalopram Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Citalopram Market Size Market Share by Application (2018-2023)
3 CITALOPRAM MARKET SIZE BY PLAYER
3.1 Citalopram Market Size Market Share by Players
3.1.1 Global Citalopram Revenue by Players (2018-2023)
3.1.2 Global Citalopram Revenue Market Share by Players (2018-2023)
3.2 Global Citalopram Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CITALOPRAM BY REGIONS
4.1 Citalopram Market Size by Regions (2018-2023)
4.2 Americas Citalopram Market Size Growth (2018-2023)
4.3 APAC Citalopram Market Size Growth (2018-2023)
4.4 Europe Citalopram Market Size Growth (2018-2023)
4.5 Middle East & Africa Citalopram Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Citalopram Market Size by Country (2018-2023)
5.2 Americas Citalopram Market Size by Type (2018-2023)
5.3 Americas Citalopram Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Citalopram Market Size by Region (2018-2023)
6.2 APAC Citalopram Market Size by Type (2018-2023)
6.3 APAC Citalopram Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Citalopram by Country (2018-2023)
7.2 Europe Citalopram Market Size by Type (2018-2023)
7.3 Europe Citalopram Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Citalopram by Region (2018-2023)
8.2 Middle East & Africa Citalopram Market Size by Type (2018-2023)
8.3 Middle East & Africa Citalopram Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CITALOPRAM MARKET FORECAST
10.1 Global Citalopram Forecast by Regions (2024-2029)
10.1.1 Global Citalopram Forecast by Regions (2024-2029)
10.1.2 Americas Citalopram Forecast
10.1.3 APAC Citalopram Forecast
10.1.4 Europe Citalopram Forecast
10.1.5 Middle East & Africa Citalopram Forecast
10.2 Americas Citalopram Forecast by Country (2024-2029)
10.2.1 United States Citalopram Market Forecast
10.2.2 Canada Citalopram Market Forecast
10.2.3 Mexico Citalopram Market Forecast
10.2.4 Brazil Citalopram Market Forecast
10.3 APAC Citalopram Forecast by Region (2024-2029)
10.3.1 China Citalopram Market Forecast
10.3.2 Japan Citalopram Market Forecast
10.3.3 Korea Citalopram Market Forecast
10.3.4 Southeast Asia Citalopram Market Forecast
10.3.5 India Citalopram Market Forecast
10.3.6 Australia Citalopram Market Forecast
10.4 Europe Citalopram Forecast by Country (2024-2029)
10.4.1 Germany Citalopram Market Forecast
10.4.2 France Citalopram Market Forecast
10.4.3 UK Citalopram Market Forecast
10.4.4 Italy Citalopram Market Forecast
10.4.5 Russia Citalopram Market Forecast
10.5 Middle East & Africa Citalopram Forecast by Region (2024-2029)
10.5.1 Egypt Citalopram Market Forecast
10.5.2 South Africa Citalopram Market Forecast
10.5.3 Israel Citalopram Market Forecast
10.5.4 Turkey Citalopram Market Forecast
10.5.5 GCC Countries Citalopram Market Forecast
10.6 Global Citalopram Forecast by Type (2024-2029)
10.7 Global Citalopram Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 H.Lundbeck A/S
11.1.1 H.Lundbeck A/S Company Information
11.1.2 H.Lundbeck A/S Citalopram Product Offered
11.1.3 H.Lundbeck A/S Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 H.Lundbeck A/S Main Business Overview
11.1.5 H.Lundbeck A/S Latest Developments
11.2 Amneal Pharmaceuticals
11.2.1 Amneal Pharmaceuticals Company Information
11.2.2 Amneal Pharmaceuticals Citalopram Product Offered
11.2.3 Amneal Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Amneal Pharmaceuticals Main Business Overview
11.2.5 Amneal Pharmaceuticals Latest Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma Citalopram Product Offered
11.3.3 Aurobindo Pharma Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Aurobindo Pharma Main Business Overview
11.3.5 Aurobindo Pharma Latest Developments
11.4 Hetero Drugs
11.4.1 Hetero Drugs Company Information
11.4.2 Hetero Drugs Citalopram Product Offered
11.4.3 Hetero Drugs Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Hetero Drugs Main Business Overview
11.4.5 Hetero Drugs Latest Developments
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Information
11.5.2 Macleods Pharmaceuticals Citalopram Product Offered
11.5.3 Macleods Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Macleods Pharmaceuticals Main Business Overview
11.5.5 Macleods Pharmaceuticals Latest Developments
11.6 Silarx Pharmacueticals
11.6.1 Silarx Pharmacueticals Company Information
11.6.2 Silarx Pharmacueticals Citalopram Product Offered
11.6.3 Silarx Pharmacueticals Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Silarx Pharmacueticals Main Business Overview
11.6.5 Silarx Pharmacueticals Latest Developments
11.7 Apotex
11.7.1 Apotex Company Information
11.7.2 Apotex Citalopram Product Offered
11.7.3 Apotex Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Apotex Main Business Overview
11.7.5 Apotex Latest Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Information
11.8.2 Hikma Pharmaceuticals Citalopram Product Offered
11.8.3 Hikma Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Hikma Pharmaceuticals Main Business Overview
11.8.5 Hikma Pharmaceuticals Latest Developments
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Information
11.9.2 Jubilant Pharma Citalopram Product Offered
11.9.3 Jubilant Pharma Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Jubilant Pharma Main Business Overview
11.9.5 Jubilant Pharma Latest Developments
11.10 Lupin Limited
11.10.1 Lupin Limited Company Information
11.10.2 Lupin Limited Citalopram Product Offered
11.10.3 Lupin Limited Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Lupin Limited Main Business Overview
11.10.5 Lupin Limited Latest Developments
11.11 Prinston Pharmaceutical
11.11.1 Prinston Pharmaceutical Company Information
11.11.2 Prinston Pharmaceutical Citalopram Product Offered
11.11.3 Prinston Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Prinston Pharmaceutical Main Business Overview
11.11.5 Prinston Pharmaceutical Latest Developments
11.12 STI Pharma
11.12.1 STI Pharma Company Information
11.12.2 STI Pharma Citalopram Product Offered
11.12.3 STI Pharma Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 STI Pharma Main Business Overview
11.12.5 STI Pharma Latest Developments
11.13 TEVA Pharmaceutical
11.13.1 TEVA Pharmaceutical Company Information
11.13.2 TEVA Pharmaceutical Citalopram Product Offered
11.13.3 TEVA Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 TEVA Pharmaceutical Main Business Overview
11.13.5 TEVA Pharmaceutical Latest Developments
11.14 Hexal
11.14.1 Hexal Company Information
11.14.2 Hexal Citalopram Product Offered
11.14.3 Hexal Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Hexal Main Business Overview
11.14.5 Hexal Latest Developments
11.15 Shanghai Great Wall Pharmaceutical
11.15.1 Shanghai Great Wall Pharmaceutical Company Information
11.15.2 Shanghai Great Wall Pharmaceutical Citalopram Product Offered
11.15.3 Shanghai Great Wall Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Shanghai Great Wall Pharmaceutical Main Business Overview
11.15.5 Shanghai Great Wall Pharmaceutical Latest Developments
11.16 Wanquan Wante Pharmaceutical
11.16.1 Wanquan Wante Pharmaceutical Company Information
11.16.2 Wanquan Wante Pharmaceutical Citalopram Product Offered
11.16.3 Wanquan Wante Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Wanquan Wante Pharmaceutical Main Business Overview
11.16.5 Wanquan Wante Pharmaceutical Latest Developments
11.17 Northeast Pharmaceutical Group
11.17.1 Northeast Pharmaceutical Group Company Information
11.17.2 Northeast Pharmaceutical Group Citalopram Product Offered
11.17.3 Northeast Pharmaceutical Group Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Northeast Pharmaceutical Group Main Business Overview
11.17.5 Northeast Pharmaceutical Group Latest Developments
11.18 Sichuan Kelun Pharmaceutical
11.18.1 Sichuan Kelun Pharmaceutical Company Information
11.18.2 Sichuan Kelun Pharmaceutical Citalopram Product Offered
11.18.3 Sichuan Kelun Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Sichuan Kelun Pharmaceutical Main Business Overview
11.18.5 Sichuan Kelun Pharmaceutical Latest Developments
11.19 Kunming Jida Pharmaceutical
11.19.1 Kunming Jida Pharmaceutical Company Information
11.19.2 Kunming Jida Pharmaceutical Citalopram Product Offered
11.19.3 Kunming Jida Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Kunming Jida Pharmaceutical Main Business Overview
11.19.5 Kunming Jida Pharmaceutical Latest Developments
11.20 Jiangsu Enhua Pharmaceutical
11.20.1 Jiangsu Enhua Pharmaceutical Company Information
11.20.2 Jiangsu Enhua Pharmaceutical Citalopram Product Offered
11.20.3 Jiangsu Enhua Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Jiangsu Enhua Pharmaceutical Main Business Overview
11.20.5 Jiangsu Enhua Pharmaceutical Latest Developments
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Company Information
11.21.2 Southwest Pharmaceutical Citalopram Product Offered
11.21.3 Southwest Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Southwest Pharmaceutical Main Business Overview
11.21.5 Southwest Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Citalopram Market Size 2018-2029
2.1.2 Citalopram Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Citalopram Segment by Type
2.2.1 Solution
2.2.2 Tablets
2.2.3 Other
2.3 Citalopram Market Size by Type
2.3.1 Citalopram Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Citalopram Market Size Market Share by Type (2018-2023)
2.4 Citalopram Segment by Application
2.4.1 Depression
2.4.2 Generalized Anxiety
2.4.3 Obsessive Compulsive Disorder
2.4.4 Somatoform Disorder
2.4.5 Schizophrenia
2.4.6 Other
2.5 Citalopram Market Size by Application
2.5.1 Citalopram Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Citalopram Market Size Market Share by Application (2018-2023)
3 CITALOPRAM MARKET SIZE BY PLAYER
3.1 Citalopram Market Size Market Share by Players
3.1.1 Global Citalopram Revenue by Players (2018-2023)
3.1.2 Global Citalopram Revenue Market Share by Players (2018-2023)
3.2 Global Citalopram Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CITALOPRAM BY REGIONS
4.1 Citalopram Market Size by Regions (2018-2023)
4.2 Americas Citalopram Market Size Growth (2018-2023)
4.3 APAC Citalopram Market Size Growth (2018-2023)
4.4 Europe Citalopram Market Size Growth (2018-2023)
4.5 Middle East & Africa Citalopram Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Citalopram Market Size by Country (2018-2023)
5.2 Americas Citalopram Market Size by Type (2018-2023)
5.3 Americas Citalopram Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Citalopram Market Size by Region (2018-2023)
6.2 APAC Citalopram Market Size by Type (2018-2023)
6.3 APAC Citalopram Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Citalopram by Country (2018-2023)
7.2 Europe Citalopram Market Size by Type (2018-2023)
7.3 Europe Citalopram Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Citalopram by Region (2018-2023)
8.2 Middle East & Africa Citalopram Market Size by Type (2018-2023)
8.3 Middle East & Africa Citalopram Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CITALOPRAM MARKET FORECAST
10.1 Global Citalopram Forecast by Regions (2024-2029)
10.1.1 Global Citalopram Forecast by Regions (2024-2029)
10.1.2 Americas Citalopram Forecast
10.1.3 APAC Citalopram Forecast
10.1.4 Europe Citalopram Forecast
10.1.5 Middle East & Africa Citalopram Forecast
10.2 Americas Citalopram Forecast by Country (2024-2029)
10.2.1 United States Citalopram Market Forecast
10.2.2 Canada Citalopram Market Forecast
10.2.3 Mexico Citalopram Market Forecast
10.2.4 Brazil Citalopram Market Forecast
10.3 APAC Citalopram Forecast by Region (2024-2029)
10.3.1 China Citalopram Market Forecast
10.3.2 Japan Citalopram Market Forecast
10.3.3 Korea Citalopram Market Forecast
10.3.4 Southeast Asia Citalopram Market Forecast
10.3.5 India Citalopram Market Forecast
10.3.6 Australia Citalopram Market Forecast
10.4 Europe Citalopram Forecast by Country (2024-2029)
10.4.1 Germany Citalopram Market Forecast
10.4.2 France Citalopram Market Forecast
10.4.3 UK Citalopram Market Forecast
10.4.4 Italy Citalopram Market Forecast
10.4.5 Russia Citalopram Market Forecast
10.5 Middle East & Africa Citalopram Forecast by Region (2024-2029)
10.5.1 Egypt Citalopram Market Forecast
10.5.2 South Africa Citalopram Market Forecast
10.5.3 Israel Citalopram Market Forecast
10.5.4 Turkey Citalopram Market Forecast
10.5.5 GCC Countries Citalopram Market Forecast
10.6 Global Citalopram Forecast by Type (2024-2029)
10.7 Global Citalopram Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 H.Lundbeck A/S
11.1.1 H.Lundbeck A/S Company Information
11.1.2 H.Lundbeck A/S Citalopram Product Offered
11.1.3 H.Lundbeck A/S Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 H.Lundbeck A/S Main Business Overview
11.1.5 H.Lundbeck A/S Latest Developments
11.2 Amneal Pharmaceuticals
11.2.1 Amneal Pharmaceuticals Company Information
11.2.2 Amneal Pharmaceuticals Citalopram Product Offered
11.2.3 Amneal Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Amneal Pharmaceuticals Main Business Overview
11.2.5 Amneal Pharmaceuticals Latest Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma Citalopram Product Offered
11.3.3 Aurobindo Pharma Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Aurobindo Pharma Main Business Overview
11.3.5 Aurobindo Pharma Latest Developments
11.4 Hetero Drugs
11.4.1 Hetero Drugs Company Information
11.4.2 Hetero Drugs Citalopram Product Offered
11.4.3 Hetero Drugs Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Hetero Drugs Main Business Overview
11.4.5 Hetero Drugs Latest Developments
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Information
11.5.2 Macleods Pharmaceuticals Citalopram Product Offered
11.5.3 Macleods Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Macleods Pharmaceuticals Main Business Overview
11.5.5 Macleods Pharmaceuticals Latest Developments
11.6 Silarx Pharmacueticals
11.6.1 Silarx Pharmacueticals Company Information
11.6.2 Silarx Pharmacueticals Citalopram Product Offered
11.6.3 Silarx Pharmacueticals Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Silarx Pharmacueticals Main Business Overview
11.6.5 Silarx Pharmacueticals Latest Developments
11.7 Apotex
11.7.1 Apotex Company Information
11.7.2 Apotex Citalopram Product Offered
11.7.3 Apotex Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Apotex Main Business Overview
11.7.5 Apotex Latest Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Information
11.8.2 Hikma Pharmaceuticals Citalopram Product Offered
11.8.3 Hikma Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Hikma Pharmaceuticals Main Business Overview
11.8.5 Hikma Pharmaceuticals Latest Developments
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Information
11.9.2 Jubilant Pharma Citalopram Product Offered
11.9.3 Jubilant Pharma Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Jubilant Pharma Main Business Overview
11.9.5 Jubilant Pharma Latest Developments
11.10 Lupin Limited
11.10.1 Lupin Limited Company Information
11.10.2 Lupin Limited Citalopram Product Offered
11.10.3 Lupin Limited Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Lupin Limited Main Business Overview
11.10.5 Lupin Limited Latest Developments
11.11 Prinston Pharmaceutical
11.11.1 Prinston Pharmaceutical Company Information
11.11.2 Prinston Pharmaceutical Citalopram Product Offered
11.11.3 Prinston Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Prinston Pharmaceutical Main Business Overview
11.11.5 Prinston Pharmaceutical Latest Developments
11.12 STI Pharma
11.12.1 STI Pharma Company Information
11.12.2 STI Pharma Citalopram Product Offered
11.12.3 STI Pharma Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 STI Pharma Main Business Overview
11.12.5 STI Pharma Latest Developments
11.13 TEVA Pharmaceutical
11.13.1 TEVA Pharmaceutical Company Information
11.13.2 TEVA Pharmaceutical Citalopram Product Offered
11.13.3 TEVA Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 TEVA Pharmaceutical Main Business Overview
11.13.5 TEVA Pharmaceutical Latest Developments
11.14 Hexal
11.14.1 Hexal Company Information
11.14.2 Hexal Citalopram Product Offered
11.14.3 Hexal Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Hexal Main Business Overview
11.14.5 Hexal Latest Developments
11.15 Shanghai Great Wall Pharmaceutical
11.15.1 Shanghai Great Wall Pharmaceutical Company Information
11.15.2 Shanghai Great Wall Pharmaceutical Citalopram Product Offered
11.15.3 Shanghai Great Wall Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Shanghai Great Wall Pharmaceutical Main Business Overview
11.15.5 Shanghai Great Wall Pharmaceutical Latest Developments
11.16 Wanquan Wante Pharmaceutical
11.16.1 Wanquan Wante Pharmaceutical Company Information
11.16.2 Wanquan Wante Pharmaceutical Citalopram Product Offered
11.16.3 Wanquan Wante Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Wanquan Wante Pharmaceutical Main Business Overview
11.16.5 Wanquan Wante Pharmaceutical Latest Developments
11.17 Northeast Pharmaceutical Group
11.17.1 Northeast Pharmaceutical Group Company Information
11.17.2 Northeast Pharmaceutical Group Citalopram Product Offered
11.17.3 Northeast Pharmaceutical Group Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Northeast Pharmaceutical Group Main Business Overview
11.17.5 Northeast Pharmaceutical Group Latest Developments
11.18 Sichuan Kelun Pharmaceutical
11.18.1 Sichuan Kelun Pharmaceutical Company Information
11.18.2 Sichuan Kelun Pharmaceutical Citalopram Product Offered
11.18.3 Sichuan Kelun Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Sichuan Kelun Pharmaceutical Main Business Overview
11.18.5 Sichuan Kelun Pharmaceutical Latest Developments
11.19 Kunming Jida Pharmaceutical
11.19.1 Kunming Jida Pharmaceutical Company Information
11.19.2 Kunming Jida Pharmaceutical Citalopram Product Offered
11.19.3 Kunming Jida Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Kunming Jida Pharmaceutical Main Business Overview
11.19.5 Kunming Jida Pharmaceutical Latest Developments
11.20 Jiangsu Enhua Pharmaceutical
11.20.1 Jiangsu Enhua Pharmaceutical Company Information
11.20.2 Jiangsu Enhua Pharmaceutical Citalopram Product Offered
11.20.3 Jiangsu Enhua Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Jiangsu Enhua Pharmaceutical Main Business Overview
11.20.5 Jiangsu Enhua Pharmaceutical Latest Developments
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Company Information
11.21.2 Southwest Pharmaceutical Citalopram Product Offered
11.21.3 Southwest Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Southwest Pharmaceutical Main Business Overview
11.21.5 Southwest Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Citalopram Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Solution
Table 3. Major Players of Tablets
Table 4. Major Players of Other
Table 5. Citalopram Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Citalopram Market Size Market Share by Type (2018-2023)
Table 8. Citalopram Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Citalopram Market Size Market Share by Application (2018-2023)
Table 11. Global Citalopram Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Citalopram Revenue Market Share by Player (2018-2023)
Table 13. Citalopram Key Players Head office and Products Offered
Table 14. Citalopram Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Citalopram Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Citalopram Market Size Market Share by Regions (2018-2023)
Table 19. Global Citalopram Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Citalopram Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Citalopram Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Citalopram Market Size Market Share by Country (2018-2023)
Table 23. Americas Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Citalopram Market Size Market Share by Type (2018-2023)
Table 25. Americas Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Citalopram Market Size Market Share by Application (2018-2023)
Table 27. APAC Citalopram Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Citalopram Market Size Market Share by Region (2018-2023)
Table 29. APAC Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Citalopram Market Size Market Share by Type (2018-2023)
Table 31. APAC Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Citalopram Market Size Market Share by Application (2018-2023)
Table 33. Europe Citalopram Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Citalopram Market Size Market Share by Country (2018-2023)
Table 35. Europe Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Citalopram Market Size Market Share by Type (2018-2023)
Table 37. Europe Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Citalopram Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Citalopram Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Citalopram Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Citalopram Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Citalopram Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Citalopram
Table 46. Key Market Challenges & Risks of Citalopram
Table 47. Key Industry Trends of Citalopram
Table 48. Global Citalopram Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Citalopram Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Citalopram Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Citalopram Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. H.Lundbeck A/S Details, Company Type, Citalopram Area Served and Its Competitors
Table 53. H.Lundbeck A/S Citalopram Product Offered
Table 54. H.Lundbeck A/S Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. H.Lundbeck A/S Main Business
Table 56. H.Lundbeck A/S Latest Developments
Table 57. Amneal Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 58. Amneal Pharmaceuticals Citalopram Product Offered
Table 59. Amneal Pharmaceuticals Main Business
Table 60. Amneal Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Amneal Pharmaceuticals Latest Developments
Table 62. Aurobindo Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 63. Aurobindo Pharma Citalopram Product Offered
Table 64. Aurobindo Pharma Main Business
Table 65. Aurobindo Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Aurobindo Pharma Latest Developments
Table 67. Hetero Drugs Details, Company Type, Citalopram Area Served and Its Competitors
Table 68. Hetero Drugs Citalopram Product Offered
Table 69. Hetero Drugs Main Business
Table 70. Hetero Drugs Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Hetero Drugs Latest Developments
Table 72. Macleods Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 73. Macleods Pharmaceuticals Citalopram Product Offered
Table 74. Macleods Pharmaceuticals Main Business
Table 75. Macleods Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Macleods Pharmaceuticals Latest Developments
Table 77. Silarx Pharmacueticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 78. Silarx Pharmacueticals Citalopram Product Offered
Table 79. Silarx Pharmacueticals Main Business
Table 80. Silarx Pharmacueticals Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Silarx Pharmacueticals Latest Developments
Table 82. Apotex Details, Company Type, Citalopram Area Served and Its Competitors
Table 83. Apotex Citalopram Product Offered
Table 84. Apotex Main Business
Table 85. Apotex Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Apotex Latest Developments
Table 87. Hikma Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 88. Hikma Pharmaceuticals Citalopram Product Offered
Table 89. Hikma Pharmaceuticals Main Business
Table 90. Hikma Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Hikma Pharmaceuticals Latest Developments
Table 92. Jubilant Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 93. Jubilant Pharma Citalopram Product Offered
Table 94. Jubilant Pharma Main Business
Table 95. Jubilant Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Jubilant Pharma Latest Developments
Table 97. Lupin Limited Details, Company Type, Citalopram Area Served and Its Competitors
Table 98. Lupin Limited Citalopram Product Offered
Table 99. Lupin Limited Main Business
Table 100. Lupin Limited Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Lupin Limited Latest Developments
Table 102. Prinston Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 103. Prinston Pharmaceutical Citalopram Product Offered
Table 104. Prinston Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Prinston Pharmaceutical Main Business
Table 106. Prinston Pharmaceutical Latest Developments
Table 107. STI Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 108. STI Pharma Citalopram Product Offered
Table 109. STI Pharma Main Business
Table 110. STI Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. STI Pharma Latest Developments
Table 112. TEVA Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 113. TEVA Pharmaceutical Citalopram Product Offered
Table 114. TEVA Pharmaceutical Main Business
Table 115. TEVA Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. TEVA Pharmaceutical Latest Developments
Table 117. Hexal Details, Company Type, Citalopram Area Served and Its Competitors
Table 118. Hexal Citalopram Product Offered
Table 119. Hexal Main Business
Table 120. Hexal Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Hexal Latest Developments
Table 122. Shanghai Great Wall Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 123. Shanghai Great Wall Pharmaceutical Citalopram Product Offered
Table 124. Shanghai Great Wall Pharmaceutical Main Business
Table 125. Shanghai Great Wall Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Shanghai Great Wall Pharmaceutical Latest Developments
Table 127. Wanquan Wante Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 128. Wanquan Wante Pharmaceutical Citalopram Product Offered
Table 129. Wanquan Wante Pharmaceutical Main Business
Table 130. Wanquan Wante Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Wanquan Wante Pharmaceutical Latest Developments
Table 132. Northeast Pharmaceutical Group Details, Company Type, Citalopram Area Served and Its Competitors
Table 133. Northeast Pharmaceutical Group Citalopram Product Offered
Table 134. Northeast Pharmaceutical Group Main Business
Table 135. Northeast Pharmaceutical Group Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Northeast Pharmaceutical Group Latest Developments
Table 137. Sichuan Kelun Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 138. Sichuan Kelun Pharmaceutical Citalopram Product Offered
Table 139. Sichuan Kelun Pharmaceutical Main Business
Table 140. Sichuan Kelun Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Sichuan Kelun Pharmaceutical Latest Developments
Table 142. Kunming Jida Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 143. Kunming Jida Pharmaceutical Citalopram Product Offered
Table 144. Kunming Jida Pharmaceutical Main Business
Table 145. Kunming Jida Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Kunming Jida Pharmaceutical Latest Developments
Table 147. Jiangsu Enhua Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 148. Jiangsu Enhua Pharmaceutical Citalopram Product Offered
Table 149. Jiangsu Enhua Pharmaceutical Main Business
Table 150. Jiangsu Enhua Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Jiangsu Enhua Pharmaceutical Latest Developments
Table 152. Southwest Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 153. Southwest Pharmaceutical Citalopram Product Offered
Table 154. Southwest Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Southwest Pharmaceutical Main Business
Table 156. Southwest Pharmaceutical Latest Developments
Table 1. Citalopram Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Solution
Table 3. Major Players of Tablets
Table 4. Major Players of Other
Table 5. Citalopram Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Citalopram Market Size Market Share by Type (2018-2023)
Table 8. Citalopram Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Citalopram Market Size Market Share by Application (2018-2023)
Table 11. Global Citalopram Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Citalopram Revenue Market Share by Player (2018-2023)
Table 13. Citalopram Key Players Head office and Products Offered
Table 14. Citalopram Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Citalopram Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Citalopram Market Size Market Share by Regions (2018-2023)
Table 19. Global Citalopram Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Citalopram Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Citalopram Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Citalopram Market Size Market Share by Country (2018-2023)
Table 23. Americas Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Citalopram Market Size Market Share by Type (2018-2023)
Table 25. Americas Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Citalopram Market Size Market Share by Application (2018-2023)
Table 27. APAC Citalopram Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Citalopram Market Size Market Share by Region (2018-2023)
Table 29. APAC Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Citalopram Market Size Market Share by Type (2018-2023)
Table 31. APAC Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Citalopram Market Size Market Share by Application (2018-2023)
Table 33. Europe Citalopram Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Citalopram Market Size Market Share by Country (2018-2023)
Table 35. Europe Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Citalopram Market Size Market Share by Type (2018-2023)
Table 37. Europe Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Citalopram Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Citalopram Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Citalopram Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Citalopram Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Citalopram Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Citalopram Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Citalopram Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Citalopram
Table 46. Key Market Challenges & Risks of Citalopram
Table 47. Key Industry Trends of Citalopram
Table 48. Global Citalopram Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Citalopram Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Citalopram Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Citalopram Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. H.Lundbeck A/S Details, Company Type, Citalopram Area Served and Its Competitors
Table 53. H.Lundbeck A/S Citalopram Product Offered
Table 54. H.Lundbeck A/S Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. H.Lundbeck A/S Main Business
Table 56. H.Lundbeck A/S Latest Developments
Table 57. Amneal Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 58. Amneal Pharmaceuticals Citalopram Product Offered
Table 59. Amneal Pharmaceuticals Main Business
Table 60. Amneal Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Amneal Pharmaceuticals Latest Developments
Table 62. Aurobindo Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 63. Aurobindo Pharma Citalopram Product Offered
Table 64. Aurobindo Pharma Main Business
Table 65. Aurobindo Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Aurobindo Pharma Latest Developments
Table 67. Hetero Drugs Details, Company Type, Citalopram Area Served and Its Competitors
Table 68. Hetero Drugs Citalopram Product Offered
Table 69. Hetero Drugs Main Business
Table 70. Hetero Drugs Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Hetero Drugs Latest Developments
Table 72. Macleods Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 73. Macleods Pharmaceuticals Citalopram Product Offered
Table 74. Macleods Pharmaceuticals Main Business
Table 75. Macleods Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Macleods Pharmaceuticals Latest Developments
Table 77. Silarx Pharmacueticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 78. Silarx Pharmacueticals Citalopram Product Offered
Table 79. Silarx Pharmacueticals Main Business
Table 80. Silarx Pharmacueticals Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Silarx Pharmacueticals Latest Developments
Table 82. Apotex Details, Company Type, Citalopram Area Served and Its Competitors
Table 83. Apotex Citalopram Product Offered
Table 84. Apotex Main Business
Table 85. Apotex Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Apotex Latest Developments
Table 87. Hikma Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 88. Hikma Pharmaceuticals Citalopram Product Offered
Table 89. Hikma Pharmaceuticals Main Business
Table 90. Hikma Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Hikma Pharmaceuticals Latest Developments
Table 92. Jubilant Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 93. Jubilant Pharma Citalopram Product Offered
Table 94. Jubilant Pharma Main Business
Table 95. Jubilant Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Jubilant Pharma Latest Developments
Table 97. Lupin Limited Details, Company Type, Citalopram Area Served and Its Competitors
Table 98. Lupin Limited Citalopram Product Offered
Table 99. Lupin Limited Main Business
Table 100. Lupin Limited Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Lupin Limited Latest Developments
Table 102. Prinston Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 103. Prinston Pharmaceutical Citalopram Product Offered
Table 104. Prinston Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Prinston Pharmaceutical Main Business
Table 106. Prinston Pharmaceutical Latest Developments
Table 107. STI Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 108. STI Pharma Citalopram Product Offered
Table 109. STI Pharma Main Business
Table 110. STI Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. STI Pharma Latest Developments
Table 112. TEVA Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 113. TEVA Pharmaceutical Citalopram Product Offered
Table 114. TEVA Pharmaceutical Main Business
Table 115. TEVA Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. TEVA Pharmaceutical Latest Developments
Table 117. Hexal Details, Company Type, Citalopram Area Served and Its Competitors
Table 118. Hexal Citalopram Product Offered
Table 119. Hexal Main Business
Table 120. Hexal Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Hexal Latest Developments
Table 122. Shanghai Great Wall Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 123. Shanghai Great Wall Pharmaceutical Citalopram Product Offered
Table 124. Shanghai Great Wall Pharmaceutical Main Business
Table 125. Shanghai Great Wall Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Shanghai Great Wall Pharmaceutical Latest Developments
Table 127. Wanquan Wante Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 128. Wanquan Wante Pharmaceutical Citalopram Product Offered
Table 129. Wanquan Wante Pharmaceutical Main Business
Table 130. Wanquan Wante Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Wanquan Wante Pharmaceutical Latest Developments
Table 132. Northeast Pharmaceutical Group Details, Company Type, Citalopram Area Served and Its Competitors
Table 133. Northeast Pharmaceutical Group Citalopram Product Offered
Table 134. Northeast Pharmaceutical Group Main Business
Table 135. Northeast Pharmaceutical Group Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Northeast Pharmaceutical Group Latest Developments
Table 137. Sichuan Kelun Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 138. Sichuan Kelun Pharmaceutical Citalopram Product Offered
Table 139. Sichuan Kelun Pharmaceutical Main Business
Table 140. Sichuan Kelun Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Sichuan Kelun Pharmaceutical Latest Developments
Table 142. Kunming Jida Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 143. Kunming Jida Pharmaceutical Citalopram Product Offered
Table 144. Kunming Jida Pharmaceutical Main Business
Table 145. Kunming Jida Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Kunming Jida Pharmaceutical Latest Developments
Table 147. Jiangsu Enhua Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 148. Jiangsu Enhua Pharmaceutical Citalopram Product Offered
Table 149. Jiangsu Enhua Pharmaceutical Main Business
Table 150. Jiangsu Enhua Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Jiangsu Enhua Pharmaceutical Latest Developments
Table 152. Southwest Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 153. Southwest Pharmaceutical Citalopram Product Offered
Table 154. Southwest Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Southwest Pharmaceutical Main Business
Table 156. Southwest Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Citalopram Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Citalopram Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Citalopram Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Citalopram Sales Market Share by Country/Region (2022)
Figure 8. Citalopram Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Citalopram Market Size Market Share by Type in 2022
Figure 10. Citalopram in Depression
Figure 11. Global Citalopram Market: Depression (2018-2023) & ($ Millions)
Figure 12. Citalopram in Generalized Anxiety
Figure 13. Global Citalopram Market: Generalized Anxiety (2018-2023) & ($ Millions)
Figure 14. Citalopram in Obsessive Compulsive Disorder
Figure 15. Global Citalopram Market: Obsessive Compulsive Disorder (2018-2023) & ($ Millions)
Figure 16. Citalopram in Somatoform Disorder
Figure 17. Global Citalopram Market: Somatoform Disorder (2018-2023) & ($ Millions)
Figure 18. Citalopram in Schizophrenia
Figure 19. Global Citalopram Market: Schizophrenia (2018-2023) & ($ Millions)
Figure 20. Citalopram in Other
Figure 21. Global Citalopram Market: Other (2018-2023) & ($ Millions)
Figure 22. Global Citalopram Market Size Market Share by Application in 2022
Figure 23. Global Citalopram Revenue Market Share by Player in 2022
Figure 24. Global Citalopram Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Citalopram Market Size 2018-2023 ($ Millions)
Figure 26. APAC Citalopram Market Size 2018-2023 ($ Millions)
Figure 27. Europe Citalopram Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Citalopram Market Size 2018-2023 ($ Millions)
Figure 29. Americas Citalopram Value Market Share by Country in 2022
Figure 30. United States Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Citalopram Market Size Market Share by Region in 2022
Figure 35. APAC Citalopram Market Size Market Share by Type in 2022
Figure 36. APAC Citalopram Market Size Market Share by Application in 2022
Figure 37. China Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Citalopram Market Size Market Share by Country in 2022
Figure 44. Europe Citalopram Market Size Market Share by Type (2018-2023)
Figure 45. Europe Citalopram Market Size Market Share by Application (2018-2023)
Figure 46. Germany Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Citalopram Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Citalopram Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Citalopram Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Citalopram Market Size 2024-2029 ($ Millions)
Figure 60. APAC Citalopram Market Size 2024-2029 ($ Millions)
Figure 61. Europe Citalopram Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Citalopram Market Size 2024-2029 ($ Millions)
Figure 63. United States Citalopram Market Size 2024-2029 ($ Millions)
Figure 64. Canada Citalopram Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Citalopram Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Citalopram Market Size 2024-2029 ($ Millions)
Figure 67. China Citalopram Market Size 2024-2029 ($ Millions)
Figure 68. Japan Citalopram Market Size 2024-2029 ($ Millions)
Figure 69. Korea Citalopram Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Citalopram Market Size 2024-2029 ($ Millions)
Figure 71. India Citalopram Market Size 2024-2029 ($ Millions)
Figure 72. Australia Citalopram Market Size 2024-2029 ($ Millions)
Figure 73. Germany Citalopram Market Size 2024-2029 ($ Millions)
Figure 74. France Citalopram Market Size 2024-2029 ($ Millions)
Figure 75. UK Citalopram Market Size 2024-2029 ($ Millions)
Figure 76. Italy Citalopram Market Size 2024-2029 ($ Millions)
Figure 77. Russia Citalopram Market Size 2024-2029 ($ Millions)
Figure 78. Spain Citalopram Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Citalopram Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Citalopram Market Size 2024-2029 ($ Millions)
Figure 81. Israel Citalopram Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Citalopram Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Citalopram Market Size 2024-2029 ($ Millions)
Figure 84. Global Citalopram Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Citalopram Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Citalopram Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Citalopram Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Citalopram Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Citalopram Sales Market Share by Country/Region (2022)
Figure 8. Citalopram Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Citalopram Market Size Market Share by Type in 2022
Figure 10. Citalopram in Depression
Figure 11. Global Citalopram Market: Depression (2018-2023) & ($ Millions)
Figure 12. Citalopram in Generalized Anxiety
Figure 13. Global Citalopram Market: Generalized Anxiety (2018-2023) & ($ Millions)
Figure 14. Citalopram in Obsessive Compulsive Disorder
Figure 15. Global Citalopram Market: Obsessive Compulsive Disorder (2018-2023) & ($ Millions)
Figure 16. Citalopram in Somatoform Disorder
Figure 17. Global Citalopram Market: Somatoform Disorder (2018-2023) & ($ Millions)
Figure 18. Citalopram in Schizophrenia
Figure 19. Global Citalopram Market: Schizophrenia (2018-2023) & ($ Millions)
Figure 20. Citalopram in Other
Figure 21. Global Citalopram Market: Other (2018-2023) & ($ Millions)
Figure 22. Global Citalopram Market Size Market Share by Application in 2022
Figure 23. Global Citalopram Revenue Market Share by Player in 2022
Figure 24. Global Citalopram Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Citalopram Market Size 2018-2023 ($ Millions)
Figure 26. APAC Citalopram Market Size 2018-2023 ($ Millions)
Figure 27. Europe Citalopram Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Citalopram Market Size 2018-2023 ($ Millions)
Figure 29. Americas Citalopram Value Market Share by Country in 2022
Figure 30. United States Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Citalopram Market Size Market Share by Region in 2022
Figure 35. APAC Citalopram Market Size Market Share by Type in 2022
Figure 36. APAC Citalopram Market Size Market Share by Application in 2022
Figure 37. China Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Citalopram Market Size Market Share by Country in 2022
Figure 44. Europe Citalopram Market Size Market Share by Type (2018-2023)
Figure 45. Europe Citalopram Market Size Market Share by Application (2018-2023)
Figure 46. Germany Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Citalopram Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Citalopram Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Citalopram Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Citalopram Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Citalopram Market Size 2024-2029 ($ Millions)
Figure 60. APAC Citalopram Market Size 2024-2029 ($ Millions)
Figure 61. Europe Citalopram Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Citalopram Market Size 2024-2029 ($ Millions)
Figure 63. United States Citalopram Market Size 2024-2029 ($ Millions)
Figure 64. Canada Citalopram Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Citalopram Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Citalopram Market Size 2024-2029 ($ Millions)
Figure 67. China Citalopram Market Size 2024-2029 ($ Millions)
Figure 68. Japan Citalopram Market Size 2024-2029 ($ Millions)
Figure 69. Korea Citalopram Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Citalopram Market Size 2024-2029 ($ Millions)
Figure 71. India Citalopram Market Size 2024-2029 ($ Millions)
Figure 72. Australia Citalopram Market Size 2024-2029 ($ Millions)
Figure 73. Germany Citalopram Market Size 2024-2029 ($ Millions)
Figure 74. France Citalopram Market Size 2024-2029 ($ Millions)
Figure 75. UK Citalopram Market Size 2024-2029 ($ Millions)
Figure 76. Italy Citalopram Market Size 2024-2029 ($ Millions)
Figure 77. Russia Citalopram Market Size 2024-2029 ($ Millions)
Figure 78. Spain Citalopram Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Citalopram Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Citalopram Market Size 2024-2029 ($ Millions)
Figure 81. Israel Citalopram Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Citalopram Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Citalopram Market Size 2024-2029 ($ Millions)
Figure 84. Global Citalopram Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Citalopram Market Size Market Share Forecast by Application (2024-2029)
